Business

Radiopharmaceuticals Market – Global Outlook and Forecast 2022-2028

Radiopharmaceuticals

Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.

This report contains market size and forecasts of Radiopharmaceuticals in global, including the following market information:

  • Global Radiopharmaceuticals Market Revenue, 2017-2022, 2023-2028, ($ millions)
  • Global Radiopharmaceuticals Market Sales, 2017-2022, 2023-2028, (K Dose)
  • Global top five Radiopharmaceuticals companies in 2021 (%)

 

The global Radiopharmaceuticals market was valued at 6956.7 million in 2021 and is projected to reach US$ 11660 million by 2028, at a CAGR of 7.7% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Diagnostic Radioisotopes Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Radiopharmaceuticals include Bracco Imaging, Bayer, Mallinckrodt, Nordion, Triad Isotopes, Lantheus, IBA Group, GE Healthcare and China Isotope & Radiation, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Radiopharmaceuticals manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Radiopharmaceuticals Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Dose)

Global Radiopharmaceuticals Market Segment Percentages, by Type, 2021 (%)

  • Diagnostic Radioisotopes
  • Therapeutic Radioisotopes

Global Radiopharmaceuticals Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Dose)

Global Radiopharmaceuticals Market Segment Percentages, by Application, 2021 (%)

  • Oncology
  • Cardiology
  • Other

Global Radiopharmaceuticals Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Dose)

Global Radiopharmaceuticals Market Segment Percentages, By Region and Country, 2021 (%)

  • North America
  • US
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Nordic Countries
  • Benelux
  • Rest of Europe
  • Asia
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Rest of Asia
  • South America
  • Brazil
  • Argentina
  • Rest of South America
  • Middle East & Africa
  • Turkey
  • Israel
  • Saudi Arabia
  • UAE
  • Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

  • Key companies Radiopharmaceuticals revenues in global market, 2017-2022 (Estimated), ($ millions)
  • Key companies Radiopharmaceuticals revenues share in global market, 2021 (%)
  • Key companies Radiopharmaceuticals sales in global market, 2017-2022 (Estimated), (K Dose)
  • Key companies Radiopharmaceuticals sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

  • Bracco Imaging
  • Bayer
  • Mallinckrodt
  • Nordion
  • Triad Isotopes
  • Lantheus
  • IBA Group
  • GE Healthcare
  • China Isotope & Radiation
  • Jubilant Pharma
  • Eli Lilly
  • Advanced Accelerator Applications
  • SIEMENS
  • Dongcheng
  • Navidea

Table of content

1 Introduction to Research & Analysis Reports
1.1 Radiopharmaceuticals Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Radiopharmaceuticals Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Radiopharmaceuticals Overall Market Size
2.1 Global Radiopharmaceuticals Market Size: 2021 VS 2028
2.2 Global Radiopharmaceuticals Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Radiopharmaceuticals Sales: 2017-2028
3 Company Landscape
3.1 Top Radiopharmaceuticals Players in Global Market
3.2 Top Global Radiopharmaceuticals Companies Ranked by Revenue
3.3 Global Radiopharmaceuticals Revenue by Companies
3.4 Global Radiopharmaceuticals Sales by Companies
3.5 Global Radiopharmaceuticals Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Radiopharmaceuticals Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Radiopharmaceuticals Product Type
3.8 Tier 1, Tier 2 and Tier 3 Radiopharmaceuticals Players in Global Market
3.8.1 List of Global Tier 1 Radiopharmaceuticals Companies
3.8.2 List of Global Tier 2 and Tier 3 Radiopharmaceuticals Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Glob

CONTACT US:
276 5th Avenue, New York, NY 10001, United States
International: +1(646)-781-7170 / +91 8087042414

Similar Reports:

Global Diagnostic Radiopharmaceuticals Market Research Report 2022 Professional Edition

Nuclear Medicine & Radiopharmaceuticals Market – Global Outlook and Forecast 2022-2028

Global Radiopharmaceuticals Market Research Report 2022 Professional Edition

Global Diagnostic Radiopharmaceuticals Market Insights and Forecast to 2028

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button